Pfizer's Irish staff worry about more job losses as drugmaker announces another €1.5bn in cuts
Pfizer said it will cut another $1.7 billion (€1.5 billion) in costs by the end of 2027. This is the third round of cuts announced by the US pharma group in the last three years and brings to $7.7 billion the amount it hopes to save in annual costs.
The company said it expected to make additional savings of $1.2 billion by increased use of automation, artificial intelligence and other digital tools. A further $500 million in savings will come from its research and development budget.
The new cuts come as the drugmaker struggles to find sources of growth amid declining demand for its vaccine and treatment for Covid-19. Pfizer is expected to lose more than $15 billion in revenue by the end of the decade as top products lose patent protection.
A series of multibillion-dollar acquisitions has yet to yield new blockbusters and Pfizer's stable of drugs in development has failed to convince Wall Street, with the company most recently pulling the plug on an experimental pill for obesity.
'Investors are just not excited about the current Pfizer business or the pipeline,' said Mizuho analyst Jared Holz. 'You could argue that nothing that they've done over the past few years has really worked, and to just watch your stock make new multiyear lows, that can't be the endgame here.'
The company, which employs some 5,000 people in Ireland, announced last October that it was cutting about 5 per cent of its Irish workforce, with about 210 jobs going across three sites: Grange Castle, West Dublin; Newbridge, Co Kildare; and Ringaskiddy, Co Cork. Read More Attribution Will Make or Break Retail Media
It also shed 100 staff from its Newbridge site in late 2023 in response to a global collapse in sales of its Paxlovid Covid antiviral medicine.
It is unclear whether the latest cost savings plan with its emphasis on automation will mean further job losses in Ireland.
The announcement came alongside publication of the drugmaker's first quarter results, with revenue of $13.7 billion falling short of analysts' $14 billion average estimate. Adjusted earnings were 92 US cents per share.
Pfizer is maintaining its 2025 outlook of between $61 billion and $64 billion and adjusted per-share earnings of $2.80 a share to $3 a share. Chief financial officer David Denton said the company is 'trending towards the upper end' of the per-share earnings guidance range.
That wasn't enough to encourage investors initially with Pfizer's shares slipping as much as 2.6 per cent after the markets opened in New York. But sentiment improved as the results were digested with the shares trading up 3.4 per cent in early afternoon trade.
Mr Denton told analysts on Tuesday that the company is forecasting $150 million in costs this year from the tariffs implemented to date. He said the sum was factored into the company's sales and earnings outlook for the year.
Pfizer, which relies on a global network of manufacturing sites to supply drugs to the US, could be significantly affected by Trump's promised tariffs on pharmaceuticals. Chief executive Albert Bourla has said the company could mitigate part of the impact by moving some overseas production into the US. Read More Bord Gáis Energy announces fresh price cuts of up to 10%
He said the industry is hoping the Trump administration will focus more on generic medicines like those the World Health Organisation has designated as essential, which tend to be produced mostly in China and India.
'I think that's where the problem is. It's not if an obesity drug is made in Ireland,' he said.
Speaking on a conference call with investors, he said the drugmaker's story over the next three years would not be one of strong revenue growth, given looming patent expirations on top products, but rather one of earnings growth.
The company's Covid business, which once drove annual revenue to $100 billion, has dramatically faded since the heights of the pandemic.
In the first quarter, Covid sales overall dragged on sales. Pfizer's Covid vaccine revenue was $565 million, beating estimates of $325 million. But Paxlovid, the company's pill for Covid, brought in $491 million, far below Wall Street's $902 million forecast.
As for other drugs, sales of Eliquis, the company's decade-old blood thinner and one of its top drugs, were $1.92 billion, roughly in line with estimates. The pneumonia vaccine Prevnar added $1.66 billion, meeting analysts' average view.
Sales of the heart drug Vyndaqel were $1.49 billion on the quarter, beating estimates of $1.38 billion despite mounting competition from BridgeBio Pharma and Alnylam Pharmaceuticals. – Additional reporting: Bloomberg
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
16 minutes ago
- New York Post
Why top NYC restaurants are bringing in famed chefs from around the world
Top New York City restaurants are increasingly turning to collaborations with renowned chefs from around the globe to boost business and stand out from high-end rivals, Side Dish has learned. The collabs, while not a new phenomenon, have taken on added importance as President Trump's tariffs create challenges for chefs to source some of their favorite ingredients. However, importing talent from all corners of the globe – which at popular Tribeca haunt l'abeille means bringing in chefs from England, France, Belgium, Japan, Hong Kong and Thailand – remains tax-free. 7 l'abeille in Tribeca is importing talent from all corners of the globe. Eric Vitale Photography 'Global residences help everyone grow and learn — from the guests to the staff. They keep the restaurant interesting,' said Howard Chang, co-owner of Kuma Hospitality Group's l'abeille with partners Rahul Saito and executive chef Mitsunobu Nagae. The dinners these top chefs serve up at ticketed events aren't cheap. At a recent, prix-fixe collab dinner at l'abeille, Nagae worked with London-based chef Chet Sharma, who studied physics at Oxford and now helms the standout Indian-themed restaurant BiBi in London's swanky Mayfair neighborhood. The meal cost $325, with an additional $295 for wine pairings. The exclusive events, however, often don't bring in more money than regular a la carte dinners, restaurateurs told Side Dish. That's because the higher prices are offset by the cost of flying in the foreign-based chefs, along with some of their team members, and putting them all up in hotels. 7 Chet Sharma, left, and Mitsunobu Nagae collaborated on a prix-fixe dinner. Eric Vitale Photography 7 The collabs, while not a new phenomenon, have taken on added importance as President Trump's tariffs create challenges for chefs to source some of their favorite ingredients. Eric Vitale Photography The upside, they say, is that global collabs raise the restaurants' profiles, bring in new diners and offer educational benefits for staff. On the Upper East Side, Sushi Noz's executive chef Nozomu Abe is bringing in Michelin-starred Chef Endo Kazutoshi, a third-generation sushi master who trained in Japan before opening his namesake restaurant, Endo, at the Rotunda in London. 7 At Sushi Noz on the Upper East Side, executive chef Nozomu Abe, left, is bringing in Michelin-starred Chef Endo Kazutoshi. Hannah Wyatt Last week, the pair offered a rare collaborative omakase where they presented their culinary visions through the use of local fish and other influences. 'We started the Japan series in 2019,' said Hannah Wyatt, Sushi Noz's operations manager. 'Our goal was to showcase top chefs from Japan through collaborative dinners with chef Noz, with a focus on sushi and kaiseki chefs at the top of their respective fields.' In Williamsburg, Brooklyn, the owners of Layla's began bringing in chefs during COVID and continue to have pop-ups for 'brand exposure.' 7 The dinners these top chefs serve up at ticketed events aren't cheap. Eric Vitale Photography 7 The exclusive events, however, often don't bring in more money than regular a la carte dinners, restaurateurs told Side Dish. Eric Vitale Photography The most recent international collab involved chef Kyle Garry and chef Whyte Rushen of Whyte's in London, who is now on a 'worldwide' tour. 'We did it once, and it was really successful and fun and now it's something we try to do as often as we can,' Samuel Lynch, one of Layla's co-owners along with Stefano D'Orsogna and David Lacey, told Side Dish. The trend has even extended to the Hamptons, where Mavericks Montauk will welcome the crew from Michelin-starred Parisian restaurant Contraste on July 31. 7 The upside, they say, is that global collabs raise the restaurants' profiles, bring in new diners and offer educational benefits for staff. Interior of l'abeille, above. Eric Vitale Photography The collaboration was made possible by the deep-rooted friendship between Mavericks' pastry chef Remy Ertaud and Contraste's Louis De Vicari. We hear … that celeb chef Scott Conant is opening a posh new Italian restaurant, Leola, in the Bahamas at Baha Mar this fall. Leola will be on the casino level of Grand Hyatt Baha Mar, joining hotspots including Jon Batiste's Jazz Club, Marcus Samuelsson's Marcus at Baha Mar Fish + Chop House, Daniel Boulud's Cafe Boulud, and Dario Cecchini's Carna. The 8,800 square foot space comes with 106 seats in the main dining room and 130 seats outside. 'Bringing Leola to life at Baha Mar is something I've dreamed about for a long time,' Conant said. 'I've always been inspired by the beauty and spirit of the Bahamas, and it felt like the perfect place to create a restaurant that's both personal and inviting. With Leola, we're blending the kind of food and hospitality I love—warm, soulful, and rooted in connection.' Conant will also participate in the Fourth Annual Bahamas Culinary & Arts Festival, which runs from Oct. 22-26.
American Press
an hour ago
- American Press
Louisiana spotlight: Nungesser keeping state top of mind for those ready to explore
Traveling has been significantly increasing since the decline during the COVID-19 pandemic — and Lt. Gov. Billy Nungesser and his team are working hard to keep Louisiana top of mind for those ready to explore. Last year, Nungesser said his office used a U.S. Commerce Department grant to increase awareness of Louisiana as a travel destination in Mumbai and New Delhi, India; Madrid, Spain; and Milan, Italy. In a few months, the team will spend a week in Canada promoting the Bayou State and its French heritage. Canada 'is about 33 percent of our international market,' Nungesser told members of the Rotary Club of Lake Charles Wednesday afternoon. 'Those Canadians love them some Louisiana.' In Paris, the Louisiana Office of Tourism also wrapped taxi cabs serving as rolling billboards to inspire travel to the state and it sponsored the London Jazz Festival last year. Nungesser said Louisiana welcomed 43 million domestic and international visitors in 2023, the most recent data available. Those visitors spent a total of $18.1 billion, an increase of 5.4 percent over 2022. International visitation showed the most significant gain, he said, increasing 16.9 percent in 2023 with spending reaching $1.7 billion. Louisiana has also been on the national stage in recent months with an alligator-themed float that crawled the streets of Pasadena, Calif., for the 136th annual Rose Parade and again as host to the Super Bowl at the Superdome in New Orleans. 'Somebody asked me what do we do better than anyone else and I said Mardi Gras,' Nungesser said. 'So we found out what parades we could go to. We were in the Macy's Thanksgiving Day Parade for three years and now we're in the Rose Parade.' Though the floats are professionally designed, they are decorated by volunteers days before the parade. Every float is covered in flowers, leaves, seeds, bark and other natural materials to honor the Rose Parade's history. Nungesser said volunteers from Louisiana are flown to California and are shuttled between the warehouse where the float is being built to their accommodations. A New Orleans native who now resides in California brings her beignets-only food truck each day to feed the volunteers during their shifts and the best of Louisiana cuisine is served each night. 'It's a trip everybody should make,' he said. For more on volunteering, visit Nungesser said participation in the parade 'allows us to drive awareness about our state as a vacation destination to a broad number of attendees, as well as viewers watching from home,' Nungesser said. 'The return on investment for the Rose Parade has been incredible.' Nungesser said the Rose Parade media coverage — thanks to a plethora of morning show interviews aired across the nation as the float is being built — for the past four years reached an estimated 10.4 billion people and was worth $144.9 million. State Parks When Nungesser took office nearly a decade ago, seven state parks were under the threat of closure. 'I was told, 'You don't have the money to keep them open and they're in pretty bad shape,' ' he said. 'Thanks to our sheriffs and local volunteers we were able to do a lot of repair and get them presentable and today those seven parks are making a profit.' The Louisiana Office of State Parks operates 21 state parks, 14 historic sites and a preservation area that comprises 45,000 acres, 110 miles of roads and 1.2 million square feet of rental facilities that welcomed more than 1.75 million visitors last year. He said his new goal is creating resort conference centers within some of the state parks to attract visiting conferences. 'We have over 350 groups that meet every year all over Louisiana,' he said. 'They don't meet in New Orleans because the hotel does not cover their per diem, but they meet everywhere else. There's usually 300-500 people and it's a great opportunity for us and it would be a great for the local economies. One thing we won't do is we won't let anyone open a restaurant (within the conference centers) or anything that would compete with local businesses.' One state park thriving at the moment is Bogue Chitto — a top destination for travelers nationwide for its mountain biking trails, which are maintained by the North Shore Off-Road Bicycling Association. 'A thousand people a month from 10-15 states go to Washington Parish for this mountain bike trail,' he said. 'We also have horseback riding. We brought a gentleman's horses into the park and let him run the business out of the park and he's knocking it out of the park, no pun intended. These two private-public partnerships have put Washington Parish on the map. Before they had very little tourism. It has changed that town forever.' Prime Video just completed a documentary on the mountain bike trails and 25 percent of the proceeds will go into building additional trails. He said the park recently acquired an additional 600 acres to expand the mountain bike and horseback riding trails. Museums Nungesser's office oversees nine museums; the Secretary of State's office and some local cities operate the rest. He said he hopes to introduce a bill next year that would force all museums to be open on the weekends — every museum operated under the Secretary of State's Office are not — when people are off work and more likely to visit. His office has also bought the website and plans to video every museum in the state. 'We did a video about the ghost that's upstairs at the Beauregard Gothic Jail — I don't know if it's there but the lady has me convinced and I'm not going up to check — and we test marketed to people who like ghosts and at Halloween, 4,000 people showed up to find that ghost,' he said. 'If you have a ghost, we will promote it and they will come.' He said most are aware of the World War II Museum in New Orleans. Now promotions will tie in Chennault Aviation and Military Museum in Monroe, the Louisiana Military Museum in Abbeville and others to draw in like-minded visitors. He also wants to give all museums the freedom to hire the directors of their choice. Right now, that responsibility falls under the office that oversees the facility. Louisiana seafood Several key pieces of legislation passed during the 2024 Regular Legislative Session affected the seafood industry in the state. Act 47 mandates restaurants serving imported crawfish or shrimp must officially inform their customers on the menu; Act 148 requires restaurants and food service establishments to label on menus all imported seafood as such, not just shrimp and crawfish; and Act 756 transferred the Seafood Safety Task Force to the Louisiana Seafood Promotion & Marketing Board to help in the regulation of imported seafood. 'We want people to ask before they eat. The goal is to prevent imported seafood — which is filled with a lot of antibiotics — to come into this country and to level the playing field for our Louisiana fishermen,' he said. 'If you eat Boudreaux's crawfish tails, they're going to be from Boudreaux's. They're not going to be from Thailand.' Keep Louisiana Beautiful Love the Boot Week is Louisiana's largest litter removal and beautification effort. During 2024, 19,441 people volunteered a total of 100,712 hours at over 760 events, removing a record 347 tons of litter in all 64 parishes. 'It has become a movement,' Nungesser said. Their efforts diverted 293 pounds of aluminum cans and 330 pounds of plastic bottles from the landfill allowing the items to be recycled. Next month, the office will be handing out buckets at marinas around the state, asking boaters and fishermen to scoop up any trash they may see on the waterways and shorelines. 'We're not going to take our foot off the gas until we have no more trash in Louisiana,' Nungesser said.
Yahoo
2 hours ago
- Yahoo
Pfizer Inc. (PFE) Finalizes Global Licensing Agreement with 3sbio, Inc.
Pfizer Inc. (NYSE:PFE) is among the . On July 24, 2025, Pfizer Inc. (NYSE:PFE) finalized the global licensing agreement with 3SBio, Inc. With this agreement, PFE acquired the exclusive rights to develop, manufacture, and commercialize 3SBio's SSGJ-707, a bispecific antibody for PD-1 and VEGF. Leveraging 3SBio's proprietary CLF2 platform, this innovative treatment enhances Pfizer's oncology pipeline and solidifies its competitive edge in cancer research. The antibody is presently undergoing clinical trials in China for non-small cell lung cancer (NSCLC) with promising interim Phase 2 results. It is also under clinical trials for gynecological tumors. By manufacturing the drug in the U.S. and expanding clinical trials globally, Pfizer Inc. (NYSE:PFE) aims to focus on Phase 3 studies for NSCLC and other solid tumors. Pfizer Inc. (NYSE:PFE) will make an upfront payment of $1.25 billion to 3SBio and acquire a $100 million equity stake, as per the agreed terms. With up to $150 million in potential payments, Pfizer Inc. (NYSE:PFE) can exercise the option to extend the agreement for exclusive rights in China. Operating globally, Pfizer Inc. (NYSE:PFE) discovers, develops, and sells biopharmaceuticals. It is one of the best ESG stocks. While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and 11 Best Mineral Stocks to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
